Dirk Holzinger

6.6k total citations · 1 hit paper
85 papers, 3.6k citations indexed

About

Dirk Holzinger is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Dirk Holzinger has authored 85 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 42 papers in Immunology and 37 papers in Hematology. Recurrent topics in Dirk Holzinger's work include Inflammasome and immune disorders (45 papers), Autoimmune and Inflammatory Disorders Research (35 papers) and Immune Response and Inflammation (15 papers). Dirk Holzinger is often cited by papers focused on Inflammasome and immune disorders (45 papers), Autoimmune and Inflammatory Disorders Research (35 papers) and Immune Response and Inflammation (15 papers). Dirk Holzinger collaborates with scholars based in Germany, Netherlands and United States. Dirk Holzinger's co-authors include Johannes Roth, Dirk Foell, Christoph Kessel, Bettina Löffler, Georg Peters, Muzaffar Hussain, Richard A. Proctor, Silke Niemann, Thomas Vogl and Sebastiaan J. Vastert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Dirk Holzinger

79 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

2018 261 citations Dirk Holzinger, Dirk Foell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dirk Holzinger Germany	33	1.8k	1.5k	1.1k	752	526	85	3.6k
Grant S. Schulert United States	33	1.5k 0.8×	1.1k 0.8×	1.5k 1.3×	1.2k 1.6×	228 0.4×	86	4.4k
Richard Mouy France	20	609 0.3×	1.1k 0.8×	884 0.8×	543 0.7×	300 0.6×	41	2.4k
Hidetoshi Takada Japan	33	937 0.5×	3.0k 2.0×	832 0.7×	660 0.9×	308 0.6×	218	5.1k
Jaak M. Vossen Netherlands	38	998 0.5×	2.1k 1.4×	2.3k 2.1×	469 0.6×	194 0.4×	119	5.3k
T. Prescott Atkinson United States	35	840 0.5×	1.6k 1.1×	483 0.4×	374 0.5×	157 0.3×	112	4.7k
Miles Parkes United Kingdom	36	1.8k 1.0×	1.7k 1.2×	287 0.3×	726 1.0×	288 0.5×	128	5.5k
Hans O. Madsen Denmark	49	1.3k 0.7×	5.6k 3.8×	1.7k 1.5×	671 0.9×	702 1.3×	144	8.6k
Bernd H. Belohradsky Germany	38	1.4k 0.8×	2.4k 1.6×	359 0.3×	740 1.0×	362 0.7×	98	5.1k
Kazunaga Agematsu Japan	42	1.3k 0.7×	3.2k 2.2×	472 0.4×	463 0.6×	289 0.5×	135	5.1k
J H Passwell Israel	29	874 0.5×	704 0.5×	301 0.3×	458 0.6×	225 0.4×	97	2.8k

Countries citing papers authored by Dirk Holzinger

Since Specialization

Citations

This map shows the geographic impact of Dirk Holzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Holzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Holzinger more than expected).

Fields of papers citing papers by Dirk Holzinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Holzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Holzinger. The network helps show where Dirk Holzinger may publish in the future.

Co-authorship network of co-authors of Dirk Holzinger

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Holzinger. A scholar is included among the top collaborators of Dirk Holzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Holzinger. Dirk Holzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jarisch, Andrea, André Willasch, Eva Rettinger, et al.. (2025). Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency. Frontiers in Immunology. 15. 1507494–1507494. 1 indexed citations

Holzinger, Dirk, et al.. (2025). Potenzial der Nachhaltigkeitswissenschaft für das Gesundheitswesen. 21(3). 258–265.

Holzinger, Dirk. (2024). Auswirkungen der Klimakrise auf die Gesundheit und Entwicklung von Kindern und Jugendlichen. Kindheit und Entwicklung. 33(4). 203–213.

Renella, Raffaele, Fabio Candotti, Cécile Jaques, et al.. (2023). PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review. Genes. 14(8). 1655–1655. 1 indexed citations

Gerß, Joachim, Ariane Klein, Gerd Horneff, et al.. (2022). Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial. Annals of the Rheumatic Diseases. 81(7). 990–997. 19 indexed citations

Laberko, Alexandra, Sarah Maier, Mario Abinun, et al.. (2020). HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome. Journal of Allergy and Clinical Immunology. 148(1). 250–255.e1. 16 indexed citations

Gohar, Faekah, Angela McArdle, Belinda Hernández, et al.. (2019). Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 78(8). 1107–1113. 17 indexed citations

Holzinger, Dirk, Toni Weinhage, Claas Hinze, et al.. (2019). Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance. American Journal of Respiratory and Critical Care Medicine. 201(5). 526–539. 41 indexed citations

Springer, Jason, Paul A. Monach, David Cuthbertson, et al.. (2018). Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. JCR Journal of Clinical Rheumatology. 24(7). 393–395. 18 indexed citations

10.

Niemann, Silke, Anne Bertling, Martin F. Brodde, et al.. (2018). Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion products. Scientific Reports. 8(1). 2185–2185. 22 indexed citations

11.

Holzinger, Dirk, Dirk Foell, & Christoph Kessel. (2018). The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases. PubMed. 5(1). 7–7. 42 indexed citations

12.

Holzinger, Dirk, et al.. (2016). The danger from within: alarmins in arthritis. Nature Reviews Rheumatology. 12(11). 669–683. 115 indexed citations

13.

Holzinger, Dirk, et al.. (2015). Biomarker für chronisch-entzündliche Erkrankungen. Zeitschrift für Rheumatologie. 74(10). 887–897. 11 indexed citations

14.

Anink, Janneke, Lisette W. A. van Suijlekom‐Smit, M.H. Otten, et al.. (2015). MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis. Arthritis Research & Therapy. 17(1). 200–200. 58 indexed citations

15.

Moncrieffe, Halima, Simona Ursu, Dirk Holzinger, et al.. (2013). A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein. Lara D. Veeken. 52(8). 1467–1476. 77 indexed citations

16.

Choi, Ivy Y., Daniëlle M. Gerlag, Rogier M. Thurlings, et al.. (2013). MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 74(3). 499–505. 119 indexed citations

17.

Schierbeck, Hanna, Rille Pullerits, Chris Pruunsild, et al.. (2013). HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration. The Journal of Rheumatology. 40(9). 1604–1613. 47 indexed citations

18.

Holzinger, Dirk, Michael Frosch, Femke H. M. Prince, et al.. (2012). The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 71(6). 974–980. 117 indexed citations

19.

Wittkowski, Helmut, J. B. Kuemmerle‐Deschner, Judith Austermann, et al.. (2011). MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes. Annals of the Rheumatic Diseases. 70(12). 2075–2081. 45 indexed citations

20.

Löffler, Bettina, Muzaffar Hussain, Matthias Grundmeier, et al.. (2010). Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils. PLoS Pathogens. 6(1). e1000715–e1000715. 331 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact